Somaxon plans financing following Silenor launch

Somaxon Pharmaceuticals Inc. (NASDAQ:SOMX) said late Thursday it is planning a follow-on underwritten by Piper Jaffray. Further terms were not disclosed. In September, Somaxon launched its Silenor dox...